Latest filings (excl ownership)
8-K
Amendments to Articles of Incorporation or Bylaws
18 Apr 24
8-K
SeaStar Medical Reports 2023 Financial Results and Provides a Business Update
17 Apr 24
10-K
2023 FY
Annual report
16 Apr 24
NT 10-K
Notice of late annual filing
1 Apr 24
8-K/A
SeaStar Medical to Restate Financials, Sets Business Update Call for April 17
27 Mar 24
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
27 Mar 24
8-K
SeaStar Medical to Restate Financials, Sets Business Update Call for April 17
27 Mar 24
8-K
Other Events
8 Mar 24
424B3
Prospectus supplement
5 Mar 24
424B3
Prospectus supplement
5 Mar 24
424B3
Prospectus supplement
5 Mar 24
424B3
Prospectus supplement
5 Mar 24
424B3
Prospectus supplement
5 Mar 24
424B3
Prospectus supplement
5 Mar 24
424B3
Prospectus supplement
5 Mar 24
424B3
Prospectus supplement
5 Mar 24
424B3
Prospectus supplement
5 Mar 24
424B3
Prospectus supplement
5 Mar 24
424B3
Prospectus supplement
5 Mar 24
424B3
Prospectus supplement
5 Mar 24
424B3
Prospectus supplement
5 Mar 24
424B3
Prospectus supplement
5 Mar 24
424B3
Prospectus supplement
5 Mar 24
424B3
Prospectus supplement
5 Mar 24
8-K
FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury
22 Feb 24
8-K
Termination of a Material Definitive Agreement
16 Feb 24
EFFECT
Notice of effectiveness
15 Feb 24
CORRESP
Correspondence with SEC
12 Feb 24
S-8
Registration of securities for employees
9 Feb 24
S-3/A
Shelf registration (amended)
9 Feb 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9 Feb 24
CORRESP
Correspondence with SEC
9 Feb 24
UPLOAD
Letter from SEC
2 Feb 24
424B5
Prospectus supplement for primary offering
30 Jan 24
8-K
SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-Market
30 Jan 24
8-K
Other Events
24 Jan 24
S-3
Shelf registration
24 Jan 24
8-K
Other Events
12 Jan 24
8-K
SeaStar Medical Appoints David A. Green as Chief Financial Officer
11 Jan 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
29 Dec 23
Latest ownership filings
4
David A Green
16 Apr 24
4
Richard D. Russell
16 Apr 24
4
Andres Lobo
16 Apr 24
4
Rick Barnett
16 Apr 24
4
Heel Kenneth Van
16 Apr 24
4
Allan Collins
16 Apr 24
4
Bruce M. Rodgers
16 Apr 24
SC 13G/A
Vellar Opportunities Fund Master, Ltd.
14 Feb 24
3
David A Green
22 Jan 24
4
Eric Schlorff
29 Nov 23
4
Kevin Chung
29 Nov 23
4
Caryl Baron
29 Nov 23
4/A
Kevin Chung
28 Nov 23
4/A
Eric Schlorff
28 Nov 23
4/A
Eric Schlorff
28 Nov 23
4
Heel Kenneth Van
27 Nov 23
4
Caryl Baron
19 Sep 23
4
Kevin Chung
19 Sep 23
4
Eric Schlorff
19 Sep 23
4
Kevin Chung
12 Sep 23
4
Eric Schlorff
12 Sep 23
4
Caryl Baron
12 Sep 23
4
Kevin Chung
17 Aug 23
4
Eric Schlorff
17 Aug 23
4
Caryl Baron
17 Aug 23
SC 13G/A
Vellar Opportunities Fund Master, Ltd.
10 Aug 23
4
Eric Schlorff
27 Jun 23
4
Caryl Baron
13 Jun 23
4
Kevin Chung
1 Jun 23
4
Richard D. Russell
30 May 23
4
Kevin Chung
22 May 23
4
Bruce M. Rodgers
10 Apr 23
4
Caryl Baron
10 Apr 23
4
Eric Schlorff
10 Apr 23
4
Allan Collins
10 Apr 23
4
Heel Kenneth Van
10 Apr 23
4
Rick Barnett
10 Apr 23
4
Andres Lobo
10 Apr 23
4
Richard D. Russell
10 Apr 23
4
Kevin Chung
7 Apr 23